dc.contributor.author | Ganapathi, R. | en |
dc.contributor.author | Kamath, N. | en |
dc.contributor.author | Constantinou, Andreas I. | en |
dc.contributor.author | Grabowski, D. | en |
dc.contributor.author | Ford, J. | en |
dc.contributor.author | Anderson, A. | en |
dc.creator | Ganapathi, R. | en |
dc.creator | Kamath, N. | en |
dc.creator | Constantinou, Andreas I. | en |
dc.creator | Grabowski, D. | en |
dc.creator | Ford, J. | en |
dc.creator | Anderson, A. | en |
dc.date.accessioned | 2019-11-04T12:50:35Z | |
dc.date.available | 2019-11-04T12:50:35Z | |
dc.date.issued | 1991 | |
dc.identifier.uri | http://gnosis.library.ucy.ac.cy/handle/7/53080 | |
dc.source | Biochemical pharmacology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025907517&doi=10.1016%2f0006-2952%2891%2990115-L&partnerID=40&md5=2d010acfc626718f2eed6b87d6232f3f | |
dc.subject | article | en |
dc.subject | doxorubicin | en |
dc.subject | priority journal | en |
dc.subject | drug resistance | en |
dc.subject | nonhuman | en |
dc.subject | Immunoblotting | en |
dc.subject | Mice | en |
dc.subject | Animal | en |
dc.subject | animal cell | en |
dc.subject | animal model | en |
dc.subject | mouse | en |
dc.subject | glycoprotein p | en |
dc.subject | Cell Nucleus | en |
dc.subject | Membrane Glycoproteins | en |
dc.subject | DNA Topoisomerases, Type II | en |
dc.subject | Phosphorylation | en |
dc.subject | Support, U.S. Gov't, P.H.S. | en |
dc.subject | protein phosphorylation | en |
dc.subject | Tumor Cells, Cultured | en |
dc.subject | Calmodulin | en |
dc.subject | cytotoxicity | en |
dc.subject | dna topoisomerase (atp hydrolysing) | en |
dc.subject | Densitometry | en |
dc.subject | dna damage | en |
dc.subject | Leukemia L1210 | en |
dc.subject | P-Glycoprotein | en |
dc.subject | Subcellular Fractions | en |
dc.subject | trifluoperazine | en |
dc.title | Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: Relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1016/0006-2952(91)90115-L | |
dc.description.volume | 41 | |
dc.description.startingpage | R21 | |
dc.description.endingpage | R26 | |
dc.author.faculty | Σχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences | |
dc.author.department | Τμήμα Βιολογικών Επιστημών / Department of Biological Sciences | |
dc.type.uhtype | Article | en |
dc.description.notes | <p>Cited By :20</p> | en |
dc.source.abbreviation | Biochem.Pharmacol. | en |
dc.contributor.orcid | Constantinou, Andreas I. [0000-0003-0365-1821] | |
dc.gnosis.orcid | 0000-0003-0365-1821 | |